keynote lectures
Learning from the Best
Brace yourselves and prepare to be inspired by four unique and inspiring personalities of the Medicine and Scientific World. Adding up to our three thematic modules, these lectures will broaden your horizons and unravel some of the most relevant topics of today.
You will also be able to learn from the best by witnessing a lifelong passion and dedication to science in our Keynote Lectures.
At the AIMS Meeting 2026, all keynote lectures are now available. Dive into the full lineup and start exploring the groundbreaking insights our speakers will bring to this year’s edition!
Explore this year’s lineup!
Speaker
Ralf Bartenschlager, PhD
Lasker-DeBakey Clinical Medical Research Award in 2016
Ralf Bartenschlager is a renowned German virologist who received the Lasker–DeBakey Clinical Medical Research Award in 2016 for his groundbreaking work on hepatitis C virus (HCV). He is best known for developing the first robust cell-culture system that allowed HCV to replicate reliably in the laboratory, an achievement that revolutionised the field.
His discovery provided scientists, for the first time, with a powerful experimental model to study the virus’s life cycle, screen antiviral compounds, and understand mechanisms of drug resistance. This work was pivotal in the development of direct-acting antivirals, the transformative therapies that now cure more than 95% of HCV infections.
Bartenschlager’s research has had profound global impact, turning what was once a chronic, often life-threatening disease into one that is now reliably curable. His contributions continue to shape modern virology and antiviral drug development.
Speaker
John Schiller, PhD
Lasker-DeBakey Clinical Medical Research Award in 2017
John Schiller is a leading American cancer researcher whose work has fundamentally transformed the prevention of virus-associated cancers. He was awarded the Lasker–DeBakey Clinical Medical Research Award in 2017, together with Douglas Lowy, for pioneering discoveries that led to the development of the first highly effective vaccines against human papillomavirus (HPV).
Schiller’s research elucidated how HPV infects human cells and how its outer proteins can be used to form virus-like particles that safely mimic the virus without containing its genetic material. This innovation enabled the creation of vaccines that induce strong, durable immunity and prevent the HPV infections responsible for cervical, anal, and other cancers.
His work has had a profound global public-health impact, providing a powerful tool to reduce the burden of HPV-related malignancies and setting a paradigm for vaccine design against other pathogens.
Speaker
Shiv Gaglani, MD, MBA
Chief Executive Officer and Co-founder of Osmosis
Shiv Gaglani is an entrepreneur and medical-education innovator best known as the co-founder of Osmosis, a learning platform that has reshaped how students and healthcare professionals master complex medical concepts. Trained as both a scientist and an MBA, he has combined analytical rigour with strategic vision to develop engaging, evidence-based educational tools used by millions worldwide.
Under his leadership, Osmosis championed a learner-centred approach, integrating clear visual explanations, adaptive learning technologies, and a mission-driven emphasis on global health. His work has significantly improved access to high-quality medical education, empowering future clinicians and strengthening the healthcare workforce.